Advanced Biomedical Technologies Stock Performance
| ABMT Stock | USD 0.0002 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Advanced Biomedical are completely uncorrelated.
Risk-Adjusted Performance
Soft
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Advanced Biomedical Technologies are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak primary indicators, Advanced Biomedical unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 5592.00 | |
| Total Cashflows From Investing Activities | -30.7 K |
Advanced |
Advanced Biomedical Relative Risk vs. Return Landscape
If you would invest 0.02 in Advanced Biomedical Technologies on November 12, 2025 and sell it today you would earn a total of 0.00 from holding Advanced Biomedical Technologies or generate 0.0% return on investment over 90 days. Advanced Biomedical Technologies is currently generating 0.8065% in daily expected returns and assumes 14.2919% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Advanced, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Advanced Biomedical Target Price Odds to finish over Current Price
The tendency of Advanced Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.0002 | 90 days | 0.0002 | about 70.39 |
Based on a normal probability distribution, the odds of Advanced Biomedical to move above the current price in 90 days from now is about 70.39 (This Advanced Biomedical Technologies probability density function shows the probability of Advanced Pink Sheet to fall within a particular range of prices over 90 days) .
Advanced Biomedical Price Density |
| Price |
Predictive Modules for Advanced Biomedical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Advanced Biomedical. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Advanced Biomedical Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Advanced Biomedical is not an exception. The market had few large corrections towards the Advanced Biomedical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Advanced Biomedical Technologies, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Advanced Biomedical within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.00 | |
β | Beta against Dow Jones | 0.00 | |
σ | Overall volatility | 0.000084 | |
Ir | Information ratio | 0.00 |
Advanced Biomedical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Advanced Biomedical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Advanced Biomedical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Advanced Biomedical is way too risky over 90 days horizon | |
| Advanced Biomedical has some characteristics of a very speculative penny stock | |
| Advanced Biomedical appears to be risky and price may revert if volatility continues | |
| Advanced Biomedical has a very high chance of going through financial distress in the upcoming years | |
| Advanced Biomedical Technologies currently holds 6.36 M in liabilities. Advanced Biomedical has a current ratio of 0.03, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Advanced Biomedical until it has trouble settling it off, either with new capital or with free cash flow. So, Advanced Biomedical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Advanced Biomedical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Advanced to invest in growth at high rates of return. When we think about Advanced Biomedical's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 123.59 K. Net Loss for the year was (672 K) with profit before overhead, payroll, taxes, and interest of 71.77 K. |
Advanced Biomedical Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Advanced Pink Sheet often depends not only on the future outlook of the current and potential Advanced Biomedical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Advanced Biomedical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 70.1 M | |
| Cash And Short Term Investments | 201.7 K |
Advanced Biomedical Fundamentals Growth
Advanced Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Advanced Biomedical, and Advanced Biomedical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Advanced Pink Sheet performance.
| Return On Asset | -0.78 | |||
| Operating Margin | (3.86) % | |||
| Current Valuation | 3.52 M | |||
| Shares Outstanding | 70.22 M | |||
| Price To Earning | (12.00) X | |||
| Price To Sales | 31.97 X | |||
| Revenue | 123.59 K | |||
| EBITDA | (282.69 K) | |||
| Cash And Equivalents | 6.98 K | |||
| Total Debt | 6.36 M | |||
| Debt To Equity | (1.04) % | |||
| Book Value Per Share | (0.12) X | |||
| Cash Flow From Operations | 646.66 K | |||
| Earnings Per Share | (0.01) X | |||
| Total Asset | 469.23 K | |||
| Retained Earnings | (2.88 M) | |||
| Current Asset | 34 K | |||
| Current Liabilities | 4.42 M | |||
About Advanced Biomedical Performance
Assessing Advanced Biomedical's fundamental ratios provides investors with valuable insights into Advanced Biomedical's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Advanced Biomedical is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. Advanced Biomedical Technologies, Inc. was founded in 2002 and is based in New York, New York. Advanced Biomedical operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 17 people.Things to note about Advanced Biomedical performance evaluation
Checking the ongoing alerts about Advanced Biomedical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Advanced Biomedical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Advanced Biomedical is way too risky over 90 days horizon | |
| Advanced Biomedical has some characteristics of a very speculative penny stock | |
| Advanced Biomedical appears to be risky and price may revert if volatility continues | |
| Advanced Biomedical has a very high chance of going through financial distress in the upcoming years | |
| Advanced Biomedical Technologies currently holds 6.36 M in liabilities. Advanced Biomedical has a current ratio of 0.03, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Advanced Biomedical until it has trouble settling it off, either with new capital or with free cash flow. So, Advanced Biomedical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Advanced Biomedical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Advanced to invest in growth at high rates of return. When we think about Advanced Biomedical's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 123.59 K. Net Loss for the year was (672 K) with profit before overhead, payroll, taxes, and interest of 71.77 K. |
- Analyzing Advanced Biomedical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Advanced Biomedical's stock is overvalued or undervalued compared to its peers.
- Examining Advanced Biomedical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Advanced Biomedical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Advanced Biomedical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Advanced Biomedical's pink sheet. These opinions can provide insight into Advanced Biomedical's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Advanced Pink Sheet Analysis
When running Advanced Biomedical's price analysis, check to measure Advanced Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Advanced Biomedical is operating at the current time. Most of Advanced Biomedical's value examination focuses on studying past and present price action to predict the probability of Advanced Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Advanced Biomedical's price. Additionally, you may evaluate how the addition of Advanced Biomedical to your portfolios can decrease your overall portfolio volatility.